©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2013; 19(48): 9359-9365
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9359
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9359
Table 3 Specific cancers diagnosed in the cohort of patients with inflammatory bowel disease between 2005 and 2011
| Location | n | Histological type |
| Urinary bladder | 4 | Urothelial carcinoma |
| Breast | 3 | Carcinoma |
| Skin | 1 | Melanoma |
| 2 | Basal cell carcinoma | |
| Appendix | 2 | Mucinous cystadenoma |
| Stomach | 1 | Adenocarcinoma |
| Pancreas | 1 | Adenocarcinoma |
| Lung | 1 | Adenocarcinoma |
| Liver | 1 | Hepatocellular carcinoma |
| Small intestine | 1 | Neuroendocrine carcinoma |
| Rectum | 1 | Carcinoid |
- Citation: Algaba A, Guerra I, Castaño &, Poza GL, Castellano VM, López M, Bermejo F. Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease. World J Gastroenterol 2013; 19(48): 9359-9365
- URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9359.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9359